z-logo
Premium
Step‐rate threshold for physical activity intensity in Parkinson’s disease
Author(s) -
Jeng Brenda,
Cederberg Katie L.,
Lai Byron,
Sasaki Jeffer E.,
Bamman Marcas M.,
Motl Robert W.
Publication year - 2020
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.13250
Subject(s) - medicine , treadmill , energy expenditure , exercise prescription , physical therapy , physical activity , preferred walking speed , physical medicine and rehabilitation
Objectives To examine the relationship between step‐rate and energy expenditure during treadmill walking in persons with PD and then further develop a step‐rate cut‐point for moderate‐to‐vigorous physical activity (MVPA) for persons with PD. Materials and Methods The sample consisted of 30 persons with mild‐to‐moderate PD and 30 controls matched by age and sex. Participants performed a 6‐minute bout of over‐ground walking at comfortable speed, and then completed three, 6‐minute bouts of treadmill walking at 13.4 m/min slower, comfortable, and 13.4 m/min faster than comfortable speeds. The three treadmill speeds were based on the initial over‐ground walking speed. The total number of steps per treadmill walking bout was recorded using a hand‐tally counter, and energy expenditure was measured using a portable, indirect spirometry system. Results The results indicated a strong association between step‐rate and energy expenditure for persons with PD ( R 2  = .92) and controls ( R 2  = .92). The analyses further indicated a steeper slope of the association for persons with PD compared with controls ( t (58) = −1.87, P <  .05), resulting in a lower step‐rate threshold ( t (58) = 2.19, P  < .05) for persons with PD (~80 steps·per minutes) than controls (~93 steps·per minutes). Conclusion Collectively, these results support the application of this disease‐specific step‐rate threshold for MVPA among persons with PD. This has important implications for physical activity promotion, prescription, and monitoring using accelerometers and pedometers for persons with PD to manage health and symptoms of PD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here